- Report
- April 2025
- 88 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 193 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 168 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 413 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 196 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 216 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 281 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 376 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 383 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 282 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 478 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 186 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 152 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 389 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- February 2025
- 316 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- April 2025
- 175 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- April 2025
- 175 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- April 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- April 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- April 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP

The Liquid Biopsy market within the Pharmaceuticals industry is a rapidly growing field of research and development. It is a minimally invasive procedure that uses a sample of blood to detect and monitor cancer. It is used to detect cancer at an early stage, to monitor the progression of the disease, and to assess the effectiveness of treatments. Liquid biopsy can also be used to detect genetic mutations associated with cancer, which can help guide treatment decisions.
The Liquid Biopsy market is expected to grow significantly in the coming years due to its potential to improve patient outcomes and reduce healthcare costs. It is also expected to benefit from advances in technology, such as the development of more sensitive and specific tests.
Some companies in the Liquid Biopsy market include Guardant Health, Exact Sciences, Biocept, and Genomic Health. Show Less Read more